Low Levels of 25-Hydroxy Vitamin D Are Independently Associated with the Risk of Bacterial Infection in Cirrhotic Patients

Overview

Journal Clin Transl Gastroenterol

Specialty Gastroenterology

Date 2014 May 30

PMID 24871371

Citations 17

Authors

Rodolphe Anty

M Tonohouan

P Ferrari-Panaia

T Piche

A Pariente

Q M Anstee

P Gual

A Tran

Affiliations

Soon will be listed here.

Abstract

Objectives: Low levels of vitamin D are associated with a higher mortality in cirrhotic patients, but the role of this deficiency is still unknown. The purpose of this study was to assess the levels of vitamin D in cirrhotic patients with and without bacterial infection.

Methods: 25-hydroxy (25-OH) vitamin D was assessed by immunoassay in 88 patients hospitalized in our hepatology unit.

Results: The causes of cirrhosis were mainly alcohol (70%), hepatitis C (10%), or both (9%). Infections (n=38) mainly included bacteriemia (21%), urinary tract infections (24%), and spontaneous bacterial peritonitis (29%). A severe deficiency in vitamin D (<10 ng/ml) was observed in 56.8% of patients. Infections were more frequent in patients with a severe deficiency compared with the others (54 vs. 29%, P=0.02). A severe deficiency in vitamin D was a predictive factor of infection (odds ratio=5.44 (1.35-21.97), P=0.017) independently of the Child-Pugh score (odds ratio=2.09 (1.47-2.97) P=0.00004) and the C-reactive protein level (odds ratio=1.03 (1.002-1.052), P=0.03) in a logistic regression also including the alanine amino transferase (not significant). By a Cox regression analysis, only the presence of an infection was significantly associated with mortality (relative risk=3.24 (1.20-8.76), P=0.02) in a model also associating the Child-Pugh score (not significant) and the presence of a severe deficiency in vitamin D (not significant).

Conclusions: Low levels of 25-OH vitamin D were independently associated with bacterial infections in cirrhotic patients. The impact of 25-OH vitamin D supplementation on the infection rate and death of cirrhotic patients should be assessed in randomized trials.

Citing Articles

Vitamin D Supplementation Is Associated with Inflammation Amelioration and Cognitive Improvement in Decompensated Patients with Cirrhosis.

Diaz-Ruiz R, Poca M, Roman E, Panadero-Gomez R, Cuyas B, Banares I Nutrients. 2025; 17(2.

PMID: 39861356 PMC: 11768058. DOI: 10.3390/nu17020226.

The Role of Vitamin D Deficiency in Hepatic Encephalopathy: A Review of Pathophysiology, Clinical Outcomes, and Therapeutic Potential.

Johnson C, Stevens C, Bennett M, Litch A, Rodrigue E, Quintanilla M Nutrients. 2024; 16(23).

PMID: 39683402 PMC: 11643663. DOI: 10.3390/nu16234007.

Bacterial Infections in Acute-on-chronic Liver Failure: Epidemiology, Diagnosis, Pathogenesis, and Management.

Xu Z, Zhang X, Chen J, Shi Y, Ji S J Clin Transl Hepatol. 2024; 12(7):667-676.

PMID: 38993512 PMC: 11233977. DOI: 10.14218/JCTH.2024.00137.

Role of Vitamin D in Liver Disease and Complications of Advanced Chronic Liver Disease.

Ravaioli F, Pivetti A, Di Marco L, Chrysanthi C, Frassanito G, Pambianco M Int J Mol Sci. 2022; 23(16).

PMID: 36012285 PMC: 9409132. DOI: 10.3390/ijms23169016.

Vitamin D-VDR Novel Anti-Inflammatory Molecules-New Insights into Their Effects on Liver Diseases.

Aggeletopoulou I, Thomopoulos K, Mouzaki A, Triantos C Int J Mol Sci. 2022; 23(15).

PMID: 35955597 PMC: 9369388. DOI: 10.3390/ijms23158465.

References

Miroliaee A, Nasiri-Toosi M, Khalilzadeh O, Esteghamati A, Abdollahi A, Mazloumi M . Disturbances of parathyroid hormone-vitamin D axis in non-cholestatic chronic liver disease: a cross-sectional study. Hepatol Int. 2010; 4(3):634-40. PMC: 2940008. DOI: 10.1007/s12072-010-9194-2. View

Gitto S, Lorenzini S, Biselli M, Conti F, Andreone P, Bernardi M . Allocation priority in non-urgent liver transplantation: An overview of proposed scoring systems. Dig Liver Dis. 2009; 41(10):700-6. DOI: 10.1016/j.dld.2009.04.018. View

Roth C, Elfers C, Figlewicz D, Melhorn S, Morton G, Hoofnagle A . Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation. Hepatology. 2011; 55(4):1103-11. DOI: 10.1002/hep.24737. View

Kwok R, Torres D, Harrison S . Vitamin D and nonalcoholic fatty liver disease (NAFLD): is it more than just an association?. Hepatology. 2013; 58(3):1166-74. DOI: 10.1002/hep.26390. View

Goel A, Gupta M, Aggarwal R . Gut microbiota and liver disease. J Gastroenterol Hepatol. 2014; 29(6):1139-48. DOI: 10.1111/jgh.12556. View

Bitetto D, Fabris C, Falleti E, Fornasiere E, Fumolo E, Fontanini E . Vitamin D and the risk of acute allograft rejection following human liver transplantation. Liver Int. 2009; 30(3):417-44. DOI: 10.1111/j.1478-3231.2009.02154.x. View

Bjelakovic G, Gluud L, Nikolova D, Whitfield K, Wetterslev J, Simonetti R . Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev. 2011; (7):CD007470. DOI: 10.1002/14651858.CD007470.pub2. View

Putz-Bankuti C, Pilz S, Stojakovic T, Scharnagl H, Pieber T, Trauner M . Association of 25-hydroxyvitamin D levels with liver dysfunction and mortality in chronic liver disease. Liver Int. 2012; 32(5):845-51. DOI: 10.1111/j.1478-3231.2011.02735.x. View

Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G . Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2006; 17(7):517-24. DOI: 10.1016/j.numecd.2006.04.002. View

10.

Rode A, Fourlanos S, Nicoll A . Oral vitamin D replacement is effective in chronic liver disease. Gastroenterol Clin Biol. 2010; 34(11):618-20. DOI: 10.1016/j.gcb.2010.07.009. View

11.

Zhang C, Zhao L, Ma L, Lv C, Ding Y, Xia T . Vitamin D status and expression of vitamin D receptor and LL-37 in patients with spontaneous bacterial peritonitis. Dig Dis Sci. 2011; 57(1):182-8. DOI: 10.1007/s10620-011-1824-6. View

12.

Kerschbaum J, Vychytil A, Lhotta K, Prischl F, Wiesholzer M, Machhold-Fabrizii V . Treatment with oral active vitamin D is associated with decreased risk of peritonitis and improved survival in patients on peritoneal dialysis. PLoS One. 2013; 8(7):e67836. PMC: 3699473. DOI: 10.1371/journal.pone.0067836. View

13.

Petta S, Ferraro D, Camma C, Cabibi D, Di Cristina A, Di Marco V . Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. Antivir Ther. 2012; 17(5):823-31. DOI: 10.3851/IMP2100. View

14.

Lange C, Bibert S, Kutalik Z, Burgisser P, Cerny A, Dufour J . A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C. PLoS One. 2012; 7(7):e40159. PMC: 3395683. DOI: 10.1371/journal.pone.0040159. View

15.

Baur K, Mertens J, Schmitt J, Iwata R, Stieger B, Eloranta J . Combined effect of 25-OH vitamin D plasma levels and genetic vitamin D receptor (NR 1I1) variants on fibrosis progression rate in HCV patients. Liver Int. 2011; 32(4):635-43. DOI: 10.1111/j.1478-3231.2011.02674.x. View

16.

Bikle D . Vitamin D regulation of immune function. Vitam Horm. 2011; 86:1-21. DOI: 10.1016/B978-0-12-386960-9.00001-0. View

17.

Bitetto D, Fattovich G, Fabris C, Ceriani E, Falleti E, Fornasiere E . Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C. Hepatology. 2011; 53(4):1118-26. DOI: 10.1002/hep.24201. View

18.

Murdoch D, Slow S, Chambers S, Jennings L, Stewart A, Priest P . Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial. JAMA. 2012; 308(13):1333-9. DOI: 10.1001/jama.2012.12505. View

19.

Moromizato T, Litonjua A, Braun A, Gibbons F, Giovannucci E, Christopher K . Association of low serum 25-hydroxyvitamin D levels and sepsis in the critically ill. Crit Care Med. 2013; 42(1):97-107. DOI: 10.1097/CCM.0b013e31829eb7af. View

20.

Kitson M, Dore G, George J, Button P, McCaughan G, Crawford D . Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection. J Hepatol. 2012; 58(3):467-72. DOI: 10.1016/j.jhep.2012.11.017. View